Therefore, SGLT2 expression in the retina may be inhibited with SGLT2 inhibitors, reduce glucose reabsorption in the eye and ultimately decrease the damaging effects of hyperglycemia [26]. This evidence concerns the gene SLC5A2 and Hyperglycemia.